The Use of Proton Pump Inhibitor on the Prevention of Gastric Cancer Bleeding
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Gwang Ha Kim, M.D., Ph.D.
Pusan National University Hospital
Principal Investigator - Il Ju Choi, M.D., Ph.D.
National Cancer Center, Korea
Principal Investigator - Moo In Park, M.D., Ph.D.
Kosin University Gospel Hospital
Principal Investigator - Won Sup Lee, M.D., Ph.D.
Gyeongsang National University Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Kosin University Gospel Hospital
Busan, South Korea
- Pusan National University Hospital
Busan, South Korea
- National Cancer Center
Goyang, South Korea
- Gyeong Sang National University Hospital
Jinju, South Korea
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2009
- Primary completion
- 30 Apr 2015
- Completion
- 31 May 2017
- Last update posted
- 4 Apr 2018
- Registered enrollment
- 394
- Registry id
- NCT02150447
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.